Successful treatment of infantile-onset ACAD9-related cardiomyopathy with a combination of sodium pyruvate, beta-blocker, and coenzyme Q10

MLA

Yuki Kawasaki, et al. “Successful Treatment of Infantile-Onset ACAD9-Related Cardiomyopathy with a Combination of Sodium Pyruvate, Beta-Blocker, and Coenzyme Q10.” Journal of Pediatric Endocrinology and Metabolism, vol. 32, Sept. 2019, pp. 1181–85. EBSCOhost, https://doi.org/10.1515/jpem-2019-0205.

APA

Yuki Kawasaki, Yosuke Murakami, Mitsuhiro Fujino, Tohru Yorifuji, Azumi Sakakibara, Yasushi Okazaki, Takumi Kadoya, Masaru Shimura, Yasutoshi Koga, Kei Murayama, Yuki Yamada, Akira Ohtake, Kana Kitayama, Rie Kawakita, & Shinji Higuchi. (2019). Successful treatment of infantile-onset ACAD9-related cardiomyopathy with a combination of sodium pyruvate, beta-blocker, and coenzyme Q10. Journal of Pediatric Endocrinology and Metabolism, 32, 1181–1185. https://doi.org/10.1515/jpem-2019-0205

Chicago

Yuki Kawasaki, Yosuke Murakami, Mitsuhiro Fujino, Tohru Yorifuji, Azumi Sakakibara, Yasushi Okazaki, Takumi Kadoya, et al. 2019. “Successful Treatment of Infantile-Onset ACAD9-Related Cardiomyopathy with a Combination of Sodium Pyruvate, Beta-Blocker, and Coenzyme Q10.” Journal of Pediatric Endocrinology and Metabolism 32 (September): 1181–85. doi:10.1515/jpem-2019-0205.